Analysed ASCENDIS PHARMA A/S (ASND:NASDAQ) News Sources
5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism
11-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
12-06-2026
yahoo.com
Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
13-06-2026
yahoo.com
Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
26-06-2026
yahoo.com
Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial
30-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading
08-07-2026
yahoo.com
What is the current price of ASCENDIS PHARMA A/S (ASND:NASDAQ)?
The current price of ASCENDIS PHARMA A/S (ASND:NASDAQ) is $270.45.
ASCENDIS PHARMA A/S (ASND:NASDAQ) absolute price change since previous trading day?
The absolute price change of ASCENDIS PHARMA A/S (ASND:NASDAQ) since the previous trading day is $-4.98.
ASCENDIS PHARMA A/S (ASND:NASDAQ) percentage price change since previous trading day?
The percentage price change of ASCENDIS PHARMA A/S (ASND:NASDAQ) since the previous trading day is -1.8081%.
What is the most recent average sentiment score for ASCENDIS PHARMA A/S (ASND:NASDAQ)?
The most recent average sentiment score for ASCENDIS PHARMA A/S (ASND:NASDAQ) is 49 out of 100.
What is the most recent average sentiment for ASCENDIS PHARMA A/S (ASND:NASDAQ)?
The most recent sentiment for ASCENDIS PHARMA A/S (ASND:NASDAQ) is .
SEC-8K** Filing Available For ASCENDIS PHARMA A/S (ASND:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.